Bleakley Financial Group’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-2,590
| Closed | -$610K | – | 524 |
|
|
2024
Q4 | $610K | Buy |
2,590
+375
| +17% | +$88.3K | 0.02% | 561 |
|
|
2024
Q3 | $609K | Buy |
2,215
+439
| +25% | +$121K | 0.02% | 540 |
|
|
2024
Q2 | $432K | Sell |
1,776
-162
| -8% | -$39.4K | 0.01% | 650 |
|
|
2024
Q1 | $290K | Sell |
1,938
-88
| -4% | -$13.2K | 0.01% | 768 |
|
|
2023
Q4 | $388K | Buy |
2,026
+404
| +25% | +$77.3K | 0.01% | 656 |
|
|
2023
Q3 | $287K | Sell |
1,622
-234
| -13% | -$41.4K | 0.01% | 699 |
|
|
2023
Q2 | $353K | Buy |
1,856
+147
| +9% | +$27.9K | 0.01% | 680 |
|
|
2023
Q1 | $342K | Sell |
1,709
-197
| -10% | -$39.5K | 0.01% | 671 |
|
|
2022
Q4 | $453K | Buy |
+1,906
| New | +$453K | 0.02% | 575 |
|